On September 1, 2026 enGene Therapeutics Inc. (Nasdaq: ENGN, "enGene" or the "Company"), a clinical-stage, non-viral genetic medicines company reported that management will participate in the following investor conferences:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Wells Fargo 21st Annual Healthcare Conference
Date: Tuesday, September 8, 2026
Time: 10:15 a.m. ET
Format: Fireside Chat
Morgan Stanley 24th Annual Global Healthcare Conference
Date: Monday, September 14, 2026
Time: 7:00 a.m. ET
Format: Fireside Chat
H.C. Wainwright 28th Annual Global Investment Conference
Date: Tuesday, September 15, 2026
Time: 1:30 p.m. ET
Format: Corporate Presentation
A live webcast of these events can be accessed on the "Events and Presentations" page under the "Investors" section of the enGene website at www.engene.com and will be archived there for 90 days.
(Press release, enGene Therapeutics, SEP 1, 2026, View Source [SID1234670510])